Since they were discovered almost three decades ago, a subset of B cells denoted as regulatory B cells (Bregs) have elicited interest throughout the immunology community. Many investigators have sought to characterize their phenotype and to understand their function and immunosuppressive mechanisms. Indeed, studies in murine models have demonstrated that Bregs possess varied phenotypic markers and could be classified into different subsets whose action and pivotal role depend on the pathological condition or stimuli. Similar conclusions were drawn in clinical settings delineating an analogous Breg population phenotypically resembling the murine Bregs that ultimately may be associated with a state of tolerance. Recent studies suggested that Bregs may play a role in the onset of autoimmune diabetes. This review will focus on deciphering the different subclasses of Bregs, their emerging role in autoimmune diabetes, and their potential use as a cell-based therapeutic.
Regulatory B Cells in Autoimmune Diabetes / M. Ben Nasr, V. Usuelli, A.J. Seelam, F. D'Addio, R. Abdi, J.F. Markmann, P. Fiorina. - In: JOURNAL OF IMMUNOLOGY. - ISSN 0022-1767. - 206:6(2021 Mar 15), pp. 1117-1125.
|Titolo:||Regulatory B Cells in Autoimmune Diabetes|
BEN NASR, MOUFIDA (Primo)
USUELLI, VERA (Secondo)
FIORINA, PAOLO (Ultimo) (Corresponding)
|Settore Scientifico Disciplinare:||Settore MED/13 - Endocrinologia|
|Data di pubblicazione:||15-mar-2021|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.4049/jimmunol.2001127|
|Appare nelle tipologie:||01 - Articolo su periodico|